<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Merck.com</provider_name><provider_url>https://www.merck.com</provider_url><author_name>Merck.com</author_name><author_url>https://www.merck.com</author_url><title>Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts - Merck.com</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="hJ6CxvXLXb"&gt;&lt;a href="https://www.merck.com/news/merck-donates-500000-to-support-river-blindness-and-lymphatic-filariasis-elimination-efforts/"&gt;Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.merck.com/news/merck-donates-500000-to-support-river-blindness-and-lymphatic-filariasis-elimination-efforts/embed/#?secret=hJ6CxvXLXb" width="600" height="338" title="&#x201C;Merck Donates $500,000 to Support River Blindness and Lymphatic Filariasis Elimination Efforts&#x201D; &#x2014; Merck.com" data-secret="hJ6CxvXLXb" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/*! This file is auto-generated */
!function(c,d){"use strict";var e=!1,o=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},!c.wp.receiveEmbedMessage)if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(t)if(t.secret||t.message||t.value)if(!/[^a-zA-Z0-9]/.test(t.secret)){for(var r,a,i,s=d.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),n=d.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),o=0;o&lt;n.length;o++)n[o].style.display="none";for(o=0;o&lt;s.length;o++)if(r=s[o],e.source===r.contentWindow){if(r.removeAttribute("style"),"height"===t.message){if(1e3&lt;(i=parseInt(t.value,10)))i=1e3;else if(~~i&lt;200)i=200;r.height=i}if("link"===t.message)if(a=d.createElement("a"),i=d.createElement("a"),a.href=r.getAttribute("src"),i.href=t.value,i.host===a.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener("message",c.wp.receiveEmbedMessage,!1),d.addEventListener("DOMContentLoaded",t,!1),c.addEventListener("load",t,!1);function t(){if(!o){o=!0;for(var e,t,r,a=-1!==navigator.appVersion.indexOf("MSIE 10"),i=!!navigator.userAgent.match(/Trident.*rv:11\./),s=d.querySelectorAll("iframe.wp-embedded-content"),n=0;n&lt;s.length;n++){if(!(r=(t=s[n]).getAttribute("data-secret")))r=Math.random().toString(36).substr(2,10),t.src+="#?secret="+r,t.setAttribute("data-secret",r);if(a||i)(e=t.cloneNode(!0)).removeAttribute("security"),t.parentNode.replaceChild(e,t);t.contentWindow.postMessage({message:"ready",secret:r},"*")}}}}(window,document);
&lt;/script&gt;
</html><description>Grants Will Be Administered through the MECTIZAN&#xAE; Donation Program and Will Support Precautionary Measures Required to Prevent the Spread of SARS-CoV-2 During Mass Drug Administration Programs for These Two Diseases Merck (NYSE: MRK), known as MSD outside the United States and Canada, and the MECTIZAN&#xAE; Donation Program (MDP), announced today a $500,000 cash donation to support non-governmental organization (NGO) partners working to eliminate river blindness (onchocerciasis) and lymphatic filariasis (LF). The funds are being provided by Merck and will be administered through an application process managed by the MDP, a public-private partnership that oversees elimination efforts of these two diseases. This funding will be offered in the form of grants to support the implementation of the World Health Organization&#x2019;s (WHO&#x2019;s) recommended precautionary measures to decrease the risk of the spread of SARS-CoV-2 during mass drug administration (MDA). This press release features multimedia.</description><thumbnail_url>https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20201022005039r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en</thumbnail_url></oembed>
